The vaccine developer once valued at $175 bln is now worth just $4 bln, excluding cash. It also has two dozen therapies in the works. Although rapid spending is a takeover deterrent, its $200 bln ...

A $466 mln London vehicle run by the US hedgie wants to turn into an insurer. Some investors say it traps them into a risky ...

S&P 500 futures fell just 1% after the president slapped tariffs on Canada, Switzerland and others. The calm reflects a solid growth and hopes that levies will fall. Yet the duties are close now. And ...

The age-appropriate internet has arrived, and Big Tech’s ad revenues may be among the victims. New British legislation has sent young social media users and other shy surfers scrambling to avoid ...

Iconic buildings don’t often change hands. Yet a trio of prime commercial properties in Hong Kong is now up for grabs. Each carries a strong connection to China's state-backed giants, which could ...